Source: Cancer Research. Unidade: FMRP
Subjects: ANTINEOPLÁSICOS, IMUNOLOGIA CELULAR, NEOPLASIAS, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANDERLEY, Carlos W. et al. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner. Cancer Research, v. 78, n. 20, p. 5891-5900, 2018Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.can-17-3480. Acesso em: 12 nov. 2024.APA
Wanderley, C. W., Colon, D. F., Luiz, J. P. M., Oliveira, F. F., Viacava, P. R., Leite, C. A., et al. (2018). Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner. Cancer Research, 78( 20), 5891-5900. doi:10.1158/0008-5472.can-17-3480NLM
Wanderley CW, Colon DF, Luiz JPM, Oliveira FF, Viacava PR, Leite CA, Pereira JA, Silva CM, Silva CR, Silva RL, Hernandez CAS, Mota JM, Alves Filho JCF, Lima-Júnior RC, Cunha TM, Cunha F de Q. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner [Internet]. Cancer Research. 2018 ; 78( 20): 5891-5900.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1158/0008-5472.can-17-3480Vancouver
Wanderley CW, Colon DF, Luiz JPM, Oliveira FF, Viacava PR, Leite CA, Pereira JA, Silva CM, Silva CR, Silva RL, Hernandez CAS, Mota JM, Alves Filho JCF, Lima-Júnior RC, Cunha TM, Cunha F de Q. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner [Internet]. Cancer Research. 2018 ; 78( 20): 5891-5900.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1158/0008-5472.can-17-3480
